Robert Dean Dally

Person

Zionsville, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
CD73 inhibitors
- Patent number 11,028,074
- Issue date Jun 8, 2021
- Eli Lilly and Company
- Robert Dean Dally
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sul...
- Patent number 9,776,992
- Issue date Oct 3, 2017
- Eli Lilly and Company
- Harold Burns Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDC7 inhibitors
- Patent number 9,156,824
- Issue date Oct 13, 2015
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective estrogen receptor modulators for the treatment of vasomot...
- Patent number 8,217,032
- Issue date Jul 10, 2012
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AKT and P70 S6 kinase inhibitors
- Patent number 8,148,387
- Issue date Apr 3, 2012
- Eli Lilly and Company
- Timothy Alan Shepherd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors
- Patent number 7,863,310
- Issue date Jan 4, 2011
- Eli Lilly and Company
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use...
- Patent number 7,745,438
- Issue date Jun 29, 2010
- Eli Lilly and Company
- Howard Barff Broughton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective estrogen receptor modulators containing a phenylsulfonyl...
- Patent number 7,585,977
- Issue date Sep 8, 2009
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazoles and benzothiazoles as inhibitors of map kinase
- Patent number 7,320,995
- Issue date Jan 22, 2008
- Eli Lilly and Company
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Patent number 6,919,371
- Issue date Jul 19, 2005
- Bayer Pharmaceuticals Corporation
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Patent number 6,660,752
- Issue date Dec 9, 2003
- Bayer Pharmaceuticals Corporation
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2-arylimino heterocycles and compositions containing th...
- Patent number 6,353,006
- Issue date Mar 5, 2002
- Bayer Corporation
- Brian R. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibition of raf kinase activity using aryl ureas
- Patent number 6,187,799
- Issue date Feb 13, 2001
- Onyx Pharmaceuticals
- Jill E Wood
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminomethylene derivaties as immunosuppressants
- Patent number 5,686,469
- Issue date Nov 11, 1997
- Miles Inc.
- Richard D. Connell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonamide aminomethylene derivatives as immunosuppressants
- Patent number 5,633,277
- Issue date May 27, 1997
- Miles Inc.
- Richard D. Connell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CD73 INHIBITORS
- Publication number 20210002257
- Publication date Jan 7, 2021
- Eli Lilly and Company
- Robert Dean DALLY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SUL...
- Publication number 20170233378
- Publication date Aug 17, 2017
- Eli Lilly and Company
- Harold Burns BROOKS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDC7 Inhibitors
- Publication number 20140275121
- Publication date Sep 18, 2014
- Eli Lilly and Company
- Robert Dean DALLY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RAF KINASE INHIBITORS
- Publication number 20120178780
- Publication date Jul 12, 2012
- Jill E. WOOD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P70 S6 KINASE INHIBITORS
- Publication number 20120071490
- Publication date Mar 22, 2012
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOT...
- Publication number 20110281847
- Publication date Nov 17, 2011
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AKT AND P70 S6 KINASE INHIBITORS
- Publication number 20100120801
- Publication date May 13, 2010
- Timothy Alan Shepherd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Raf Kinase Inhibitors
- Publication number 20100063088
- Publication date Mar 11, 2010
- Jill E. WOOD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P70 S6 KINASE INHIBITORS
- Publication number 20090163714
- Publication date Jun 25, 2009
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective Estrogen Receptor Modulators for the Treatment of Vasomot...
- Publication number 20090023917
- Publication date Jan 22, 2009
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors
- Publication number 20080227839
- Publication date Sep 18, 2008
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE ESTROGEN RECEPTOR MODULATORS CONTAINING A PHENYLSULFONYL...
- Publication number 20080214612
- Publication date Sep 4, 2008
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use...
- Publication number 20070225267
- Publication date Sep 27, 2007
- Howard Barff Broughton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLIDINE DERIVATIVES USEFUL AS BASE INHIBITORS
- Publication number 20070213331
- Publication date Sep 13, 2007
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective estrogen receptor modulators
- Publication number 20070111988
- Publication date May 17, 2007
- Eli Lilly and Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective estrogen receptor modulators containing a phenylsulfonyl...
- Publication number 20060183736
- Publication date Aug 17, 2006
- Elililly And Company
- Robert Dean Dally
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzimidazoles and benzothiazoles as inhibitors of map kinase
- Publication number 20050272791
- Publication date Dec 8, 2005
- Eil Lilly and Company
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Raf kinase inhibitors
- Publication number 20050256174
- Publication date Nov 17, 2005
- Jill E. Wood
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Publication number 20050215594
- Publication date Sep 29, 2005
- Bayer Pharmaceuticals Corporation
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Publication number 20040072828
- Publication date Apr 15, 2004
- Bayer Pharmaceuticals Corporation
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclic and acyclic amidines and pharmaceutical compositions contain...
- Publication number 20030229072
- Publication date Dec 11, 2003
- William H Bullock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted 2-arylimino heterocycles and compositions containing th...
- Publication number 20030207865
- Publication date Nov 6, 2003
- Brian R. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Publication number 20030078260
- Publication date Apr 24, 2003
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Raf kinase inhibitors
- Publication number 20010006975
- Publication date Jul 5, 2001
- BAYER CORPORATION and ONYX PHARMACEUTICALS West Haven, CT and Richmond, CA, r...
- Jill E. Wood
- C07 - ORGANIC CHEMISTRY

Robert Dean Dally

Person

Patents Grantslast 30 patents

CD73 inhibitors

1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sul...

CDC7 inhibitors

Selective estrogen receptor modulators for the treatment of vasomot...

AKT and P70 S6 kinase inhibitors

Kinase inhibitors

3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use...

Selective estrogen receptor modulators containing a phenylsulfonyl...

Benzimidazoles and benzothiazoles as inhibitors of map kinase

2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor...

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...

Substituted 2-arylimino heterocycles and compositions containing th...

Inhibition of raf kinase activity using aryl ureas

Aminomethylene derivaties as immunosuppressants

Sulfonamide aminomethylene derivatives as immunosuppressants

Patents Applicationslast 30 patents

CD73 INHIBITORS

1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SUL...

CDC7 Inhibitors

RAF KINASE INHIBITORS

P70 S6 KINASE INHIBITORS

SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOT...

AKT AND P70 S6 KINASE INHIBITORS

Raf Kinase Inhibitors

P70 S6 KINASE INHIBITORS

Selective Estrogen Receptor Modulators for the Treatment of Vasomot...

Kinase Inhibitors

SELECTIVE ESTROGEN RECEPTOR MODULATORS CONTAINING A PHENYLSULFONYL...

3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use...

PYRROLIDINE DERIVATIVES USEFUL AS BASE INHIBITORS

Selective estrogen receptor modulators

Selective estrogen receptor modulators containing a phenylsulfonyl...

Benzimidazoles and benzothiazoles as inhibitors of map kinase

Raf kinase inhibitors

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...

Cyclic and acyclic amidines and pharmaceutical compositions contain...

Substituted 2-arylimino heterocycles and compositions containing th...

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...

Raf kinase inhibitors